Traditional public health surveillance operates like a camera with a low-resolution lens. It can tell you that an outbreak is happening, or how many people are testing positive, but it routinely misses the underlying genetic shifts that dictate how a pathogen spreads, evades vaccines, or develops drug resistance. This disconnect is known as the genomic surveillance gap.
To understand why this gap matters, imagine tracking a respiratory outbreak or a spike in hospital infections using only binary diagnostic tests (positive/negative). As Lin et al. (2007) point out, binary results lack the sequence-level resolution required to monitor antigenic drift and evolutionary changes in real time. Without this granularity, public health systems are left blind to the precise mechanisms driving transmission and treatment failure.
The Resolution Illusion: Acquired vs. Transmitted Resistance
When a patient fails to respond to antibiotics, traditional clinical records leave a fundamental question unanswered: Did the pathogen mutate and acquire resistance within that individual due to treatment pressure, or did the patient contract an already resistant strain via primary transmission?
Without high-resolution molecular genotyping or whole-genome sequencing (WGS), answering this is impossible. For instance, a 10-year retrospective study on drug-resistant tuberculosis in Hunan, China (Epidemiology of drug–resistant tuberculosis in Hunan China over a 10–year period) highlights that the absence of molecular genotyping prevents public health interventions from accurately targeting the root cause of resistance spread. If resistance is acquired, the solution lies in better treatment adherence; if it is transmitted, the focus must shift to breaking transmission chains.
Similarly, in intensive care units, Jung et al. (2024) demonstrated that evaluating contact precautions against carbapenem-resistant Enterobacterales (CRE) is severely limited without molecular typing. Without it, clinicians cannot distinguish between horizontal transmission between patients and the spontaneous emergence of resistance within an individual, leaving the true efficacy of infection control measures unconfirmed.
Traditional Surveillance: [Patient Positive] ───> [Treat with Antibiotics] ───> [Failure: Why?]
│
Genomic Surveillance: [Sequence Strain] ───> Identifies Clonal Lineage ──────────┴─> [Distinguish Acquired vs. Transmitted]
Distinguishing Local Evolution from Importation
The genomic surveillance gap also distorts our understanding of spatial dynamics. When an outbreak occurs, public health officials must determine whether the pathogen is endemic—sustained by local, continuous transmission—or frequently re-introduced from external regions.
Struchiner et al. (2015) noted this limitation when analyzing dengue incidence in Singapore; without genomic evidence, confirming whether outbreaks are driven by local viral evolution or external importation remains difficult. This challenge extends to global scales: Hayee et al. (2021) observed that a lack of original genomic sequencing data during Pakistan's third COVID-19 wave made it difficult to differentiate between the impact of imported variants and local mutations.
When high-resolution data is integrated, the insights can revolutionize intervention strategies. Chung (2023) introduced the concept of "genetic connectivity" by leveraging viral phylogenetics to map real-world transmission intensity across geographic boundaries. By bridging the gap between phylogenetic trees and spatial spread models, Chung (2023) demonstrated that targeted interventions on high-connectivity routes could match the efficiency of broad lockdowns with far less disruption.
The Missing Link Between Genetics and Actionable Epidemiology
Even when genomic sequencing is deployed, a secondary gap often emerges: the disconnect between identifying a genetic link and determining the actionable behavioral or environmental pathway that caused the transmission.
As Sundermann et al. (2025) explain, while WGS can confirm that a cluster of hospital infections originated from the same source, it does not inherently reveal how it spread—whether via a shared medical procedure, a specific healthcare provider, or contaminated equipment. To bridge this, the authors developed an AI tool pairing WGS with Bayesian inference to automate the detection of these hidden epidemiological pathways.
Without this integration, statistical correlations remain unverified. For example, Miller et al. (2024) used insurance claims to show that a family member returning from a hospital increases the risk of household MRSA infections. However, the authors noted that the absence of genomic sequencing made it impossible to definitively link the specific bacterial strains, leaving the transmission chain unconfirmed by molecular evidence.
Longitudinal Blind Spots and Animal Reservoirs
Pathogen evolution is a continuous process, yet genomic surveillance is frequently episodic or geographically restricted. This lack of longitudinal tracking creates massive blind spots, particularly in high-density urban environments and zoonotic reservoirs where new variants quietly brew.
Francisco et al. (2021) emphasized that many regions struggle to maintain continuous, high-resolution genomic surveillance, creating gaps in understanding how lineages emerge and compete locally. This is echoed in a seven-year study of Enterovirus D68 in Shanghai (Clinical and molecular epidemiology of enterovirus D68 from 2013 to 2020 in Shanghai), which noted that a lack of long-term molecular surveillance in dense urban hubs makes it difficult to track the genetic instability and recombination events that precede large-scale public health crises.
The gap is even wider at the human-animal interface. Zhu (2011) leveraged a decade of systematic swine influenza surveillance to reveal highly erratic evolutionary dynamics driven by intercontinental gene flow and frequent reassortment. Zhu (2011) argued that without continuous genetic monitoring of major livestock hubs, the transition of viruses from animal populations to humans remains incredibly difficult to predict or reconstruct. Similarly, Pain (2008) noted that a lack of high-resolution genomic data for parasites infecting non-human primates limits our ability to track emerging zoonotic threats before they jump species.
Moving Toward Next-Generation Surveillance
Closing the genomic surveillance gap requires moving beyond isolated sequencing projects toward integrated, real-time data networks. Rabadán (2009) envisioned a framework for "Next Generation Syndromic Surveillance" that breaks down the silos between molecular biology and clinical medicine by linking real-time viral sequencing directly with Electronic Health Records (EHRs).
Currently, the logistical difficulties of physical specimen collection and the absence of standardized international protocols (Global distribution of antimicrobial resistance genes in aquaculture) continue to stall this vision. As He (2025) notes regarding shifting influenza patterns, expanding international data-sharing networks is essential to transition from reactive outbreak responses to proactive, predictive viral tracking.
Key Foundational Work
Application of Broad-Spectrum, Sequence-Based Pathogen Identification in an Urban Population (2007) — contributed 1 concept elements to this direction.
A mutagenetic tree hidden Markov model for longitudinal clonal HIV sequence data (2006) — contributed 1 concept elements to this direction.